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Introduction
Loss of function mutations of the intracellular enzyme 3’
repair exonuclease (TREX) 1 cause Aicardi-Goutières syn-
drome (AGS). As AGS clinically overlaps with systemic
lupus erythematosus (SLE) and, like SLE, features a spon-
taneous activation of the antiviral type I-interferon (IFN)
system as well as production of antinuclear autoantibodies,
this condition may be considered a monogenic variant of
SLE. TREX1-deficient mice spontaneously develop multi-
organ autoimmune disease that is fully dependent on a
functional type I-IFN system. This phenotype suggested a
new concept of systemic autoimmunity arising from intra-
cellular accumulations of (so far enigmatic) nucleic acid
substrates of TREX1, which trigger chronic antiviral IFN
responses and thereby autoimmunity. Nonhematopoietic
cells were proposed to be the cellular source of the patho-
genic IFN. Uncontrolled activity of endogenous retroele-
ments was suspected to induce the chronic antiviral
response.
Objectives
We sought to identify cell types responsible for the loss
of self tolerance and to clarify whether there is a role
for endogenous retroelements in the disease of TREX1-
deficient mice.
Materials and methods
In order to elucidate the role of Trex1 in the hemato-
poietic system, lethally irradiated mice were reconstituted
with TREX-/- fetal liver cells. Furthermore we generated a
Trex1 flox mouse line which was used to specifically
delete TREX1 in CD11c-expressing cells (CD11c-Cre), in
DCs (Clec9a-Cre), and in B cells (CD19-Cre). To test a
potential role of retroelements, TREX1-/- were crossed to
transgenic retrotransposition reporter mice and were
treated with reverse transcriptase inhibitors.
Results
While Cre/loxP-mediated conditional inactivation of
Trex1 in various non-hematopoietic compartments did
not result in detectable inflammatory disease, selective
knock out in the hematopoietic system largely reproduced
the TREX1-/- phenotype. Mice with inactivation of the
Trex1 gene in DCs developed only mild autoimmunity,
but featured massive upregulation of interferon stimulated
genes suggesting a critical pathogenic role of DCs. Inter-
estingly, selective loss of TREX1 in CD19+ B cells did not
result in a detectable activation of the type I-interferon
system.
Treatment of TREX1-/- mice with the reverse transcrip-
tase inhibitor Truvada® did not ameliorate the phenotype.
Retrotransposition events were not increased in frequency
in a TREX1-/- compared to a wildtype background.
Conclusion
We demonstrate that specific cell types differentially
respond to the loss of TREX1 and show that DCs are an
important source of type I IFN in the TREX1-/- model.
Our findings that loss of TREX1 had no impact on Line1
retrotransposition and that pharmacological inhibition of
retrotransposition in vivo did not rescue TREX1-/-mice
from lethality challenges the concept of a pathogenic role
of endogenous retroelements in this model.
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